J7207 HCPCS Level II code: Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
J7207 is the HCPCS code for “Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
Short description: Factor viii pegylated recomb
HCPCS · United States
Notes for J7207
As CMS prints them, with any note J7207 takes from the headings above it.
Note
- CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.
Medicare details
The indicators CMS publishes with J7207 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2017
Where J7207 sits
- 1J codesDrugs administered other than orally
- 2Active code J7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7207 mean?
J7207 is the HCPCS code for “Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7207?
CMS lists J7207’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7207
All J codesJ7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iuJ7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iuJ7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iuJ7205Injection, factor viii fc fusion protein (recombinant), per iuJ7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgramJ7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.